648 — SoftMedx Healthcare Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 10950.28% | ||
Return on Equity | n/a | ||
Operating Margin | 602.64% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 9.62 | 1.7 | 33.77 | 51.34 | 54.64 | n/a | n/a | 6.35% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | +580.31 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
SoftMedx Healthcare Ltd, formely China Wah Yan Healthcare Ltd, is an investment holding company principally engaged in the medical and healthcare businesses. The Company operates through three segments. The Medical and Well-being segment is engaged in the operation of medical centres specialising in the diagnosis and treatment of tumour. The Segment is also engaged in the operation of optical products and eye-care services retail shops. The Segment is also engaged in the manufacturing and sale of pharmaceutical and health related products. In addition, the Segment is engaged in the provision of medical laboratory testing services, health check services and obstetric and gynaecological services. The Health Management segment is engaged in the operation of sports and healthcare clubhouses. The Asset Management segment is engaged in the investment in financial assets, fixed assets and distressed assets, as well as loan financing.
Directors
- Wai Kwan Cheung EDR (53)
- Jianguo Wang EDR (51)
- Sung Him Lam SEC
- Ka Chung Chan DRC (45)
- Yee Ping Chan NID (43)
- Xuezhen Hu NID (48)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 20th, 1989
- Public Since
- October 29th, 1990
- No. of Employees
- 21
- Sector
- Hotels & Entertainment Services
- Industry
- Consumer Cyclicals
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 326,036,828

- Address
- 36th Floor, Times Tower
- Web
- http://www.648.com.hk/
- Phone
- +852 null21873085
- Auditors
- CL Partners CPA Limited
Upcoming Events for 648
Similar to 648
1957 & Co (Hospitality)
Stock Exchange of Hong Kong Limited
AGTech Holdings
Stock Exchange of Hong Kong Limited
Ajisen (China) Holdings
Stock Exchange of Hong Kong Limited
Asia Pioneer Entertainment Holdings
Stock Exchange of Hong Kong Limited
Bar Pacific group
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:21 UTC, shares in SoftMedx Healthcare are trading at HK$0.38. This share price information is delayed by 15 minutes.
Shares in SoftMedx Healthcare last closed at HK$0.38 and the price had moved by -20.83% over the past 365 days. In terms of relative price strength the SoftMedx Healthcare share price has underperformed the FTSE Developed Asia Pacific Index by -19.93% over the past year.
There is no consensus recommendation for this security.
Find out moreSoftMedx Healthcare does not currently pay a dividend.
SoftMedx Healthcare does not currently pay a dividend.
SoftMedx Healthcare does not currently pay a dividend.
To buy shares in SoftMedx Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.38, shares in SoftMedx Healthcare had a market capitalisation of .
Here are the trading details for SoftMedx Healthcare:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 648
Based on an overall assessment of its quality, value and momentum SoftMedx Healthcare is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SoftMedx Healthcare. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +5.96%.
As of the last closing price of HK$0.38, shares in SoftMedx Healthcare were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SoftMedx Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
SoftMedx Healthcare's management team is headed by:
- Wai Kwan Cheung - EDR
- Jianguo Wang - EDR
- Sung Him Lam - SEC
- Ka Chung Chan - DRC
- Yee Ping Chan - NID
- Xuezhen Hu - NID